September 8, 2023 - September 12, 2023

Unihealth Consultancy IPO Review & Recommendations

Dilip Davda has given "Apply" recommendation to Unihealth Consultancy IPO.

Unihealth Consultancy IPO Review Summary from brokers and analysts

Review By	Apply	May Apply	Neutral	Avoid	Not Rated
Count	1	0	0	0	0
%	100.00	0.00	0.00	0.00	0.00

Unihealth Consultancy IPO Analysis By Brokers/Analysts

Reviewer	Recommendation	Past Reviews
Dilip Davda	Apply

Unihealth Consultancy IPO Review by Dilip Davda (Apply)

[Dilip Davda] The company has healthcare services/product distribution centres in India and the African continent. Considering the business tie-ups between India and Africa on healthcare, this company is poised for bright prospects ahead. FY23 financial performance hints at the opportunities lying ahead. Investors may park funds for short to long-term rewards. Read detail review...

Unihealth Consultancy IPO Peer Comparison

Unihealth Consultancy Limited peer comparison with similar listed entities. (Consolidated) (As on March 31, 2023)

Company Name	EPS (Rs)		NAV (per share) (Rs)	P/E (x)	RoNW (%)
Company Name	EPS Basic	EPS Diluted	NAV (per share) (Rs)	P/E (x)	RoNW (%)
Unihealth Consultancy Limited	6.94	6.94			27.91
KMC Speciality Hospitals (India) Ltd	1.64	1.64	6.96	44.88	23.51

Notes:

The financial information for listed industry peers mentioned above is consolidated basis (if applicable) sourced from the Annual Reports of the peer company uploaded on the BSE website for the year ended March 31, 2023.
P/E Ratio has been computed based on the closing market price of equity shares on the BSE website on August 24, 2023, divided by the Diluted EPS.
RoNW is computed as net profit after tax divided by the closing net worth. Net worth has been computed as the sum of share capital, reserves, and surplus.
NAV is computed as the closing net worth divided by the weighted average outstanding number of equity shares.

Unihealth Consultancy IPO Review by Members

Unihealth Consultancy IPO Reviews, analysis and views by popular members. Read Unihealth Consultancy Limited IPO reviews by retail investors to find recommended ipo to buy.

Post Recommendation Manage Your IPO Reviews

Unihealth Consultancy IPO Review Summary by Members

Review By	Apply	May Apply	Neutral	Avoid
Count	0	0	1	0
%	0.00	0.00	100.00	0.00

Member	Review
Mr G	Neutral good issue but on a very high valuation so one may apply as the sector is good and they are having there presence in abroad as well September 4, 2023 2:56:23 PM

Member

Review

Mr G

Neutral

good issue but on a very high valuation so one may apply as the sector is good and they are having there presence in abroad as well

September 4, 2023 2:56:23 PM

Post Recommendation Manage Recommendations

Note:

The recommendations or analysis of public issues posted above expresses the views of its author and does not represent the views of Chittorgarh.com or its staff.
We reserve the right to remove any objectionable post without providing a reason.